Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–8.

Article  PubMed  Google Scholar 

Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Göcze I, Jauch D, Götz M, Kennedy P, Jung B, Zeman F, Gnewuch C, Graf BM, Gnann W, Banas B, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg. 2018;267(6):1013–20.

Article  PubMed  Google Scholar 

Zarbock A, Küllmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, Rajani R, McCorkell S, Arndt C, Wulf H, et al. Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292–302.

Article  CAS  PubMed  Google Scholar 

von Groote TC, Ostermann M, Forni LG, Meersch-Dini M, Zarbock A. The AKI care bundle: all bundle components are created equal-are they? Intensive Care Med. 2022;48(2):242–5.

Article  Google Scholar 

Kashani K, Rosner MH, Ostermann M. Creatinine: from physiology to clinical application. Eur J Intern Med. 2020;72:9–14.

Article  CAS  PubMed  Google Scholar 

Hasson D, Menon S, Gist KM. Improving acute kidney injury diagnostic precision using biomarkers. Pract Lab Med. 2022;30:e00272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parikh CR, Mansour SG. Perspective on clinical application of biomarkers in AKI. J Am Soc Nephrol. 2017;28(6):1677–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, Bell M, Forni L, Guzzi L, Joannidis M. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209–e2019209.

Article  PubMed  Google Scholar 

Pan HC, Yang SY, Chiou TT, Shiao CC, Wu CH, Huang CT, Wang TJ, Chen JY, Liao HW, Chen SY, et al. Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis. Crit Care. 2022;26(1):349.

Article  PubMed  PubMed Central  Google Scholar 

Ernst A, Köhrle J, Bergmann A. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation. Peptides. 2006;27(7):1835–40.

Article  CAS  PubMed  Google Scholar 

Jordan BA, Cvejic S, Devi LA. Opioids and their complicated receptor complexes. Neuropsychopharmacology. 2000;23(4 Suppl):S5-s18.

Article  CAS  PubMed  Google Scholar 

Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwaßer A, Jaffe AS. Analytical performance of an immunoassay to measure proenkephalin. Clin Biochem. 2018;58:72–7.

Article  CAS  PubMed  Google Scholar 

Khorashadi M, Beunders R, Pickkers P, Legrand M. Proenkephalin: a new biomarker for glomerular filtration rate and acute kidney injury. Nephron. 2020;144(12):655–61.

Article  CAS  PubMed  Google Scholar 

Rosenqvist M, Bronton K, Hartmann O, Bergmann A, Struck J, Melander O. Proenkephalin a 119-159 (penKid): a novel biomarker for acute kidney injury in sepsis: an observational study. BMC Emerg Med. 2019;19(1):75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breidthardt T, Jaeger C, Christ A, Klima T, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Badertscher P, Struck J, et al. Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease. Eur J Clin Invest. 2018;48(10):e12999.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003;327(7414):557–60.

Article  Google Scholar 

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.

Article  PubMed  Google Scholar 

Liu C, Lu X, Mao Z, Kang H, Liu H, Pan L, Hu J, Wang L, Zhou F. The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis. Medicine. 2017;96(27):e7484.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17(1):R2.

Article  PubMed  PubMed Central  Google Scholar 

Drevon D, Fursa SR, Malcolm AL. Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data. Behav Modif. 2017;41(2):323–39.

Article  PubMed  Google Scholar 

Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865–84.

Article  CAS  PubMed  Google Scholar 

Steinhauser S, Schumacher M, Rücker G. Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies. BMC Med Res Methodol. 2016;16(1):97.

Article  PubMed  PubMed Central  Google Scholar 

Wang JJ, Chi NH, Huang TM, Connolly R, Chen LW, Chueh SJ, Kan WC, Lai CC, Wu VC, Fang JT, et al. Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery. Crit Care. 2018;22(1):108.

Article  PubMed  PubMed Central  Google Scholar 

O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics 1979:549–556.

Chen SY, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, Lin YH, Wu VC, Study Group T. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022; 187(6):S47–58.

Su CC, Chen JY, Chen SY, Shiao CC, Neyra JA, Matsuura R, Noiri E, See E, Chen YT, Hsu CK, et al. Outcomes associated with acute kidney disease: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101760.

Article  PubMed  Google Scholar 

Pan HC, Chen YY, Tsai IJ, Shiao CC, Huang TM, Chan CK, Liao HW, Lai TS, Chueh Y, Wu VC, et al. Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies. Crit Care. 2021;25(1):5.

Article  PubMed  PubMed Central  Google Scholar 

Shah KS, Taub P, Patel M, Rehfeldt M, Struck J, Clopton P, Mehta RL, Maisel AS. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol. 2015;83(1):29–35.

Article  CAS  PubMed  Google Scholar 

Mossanen JC, Pracht J, Jansen TU, Buendgens L, Stoppe C, Goetzenich A, Struck J, Autschbach R, Marx G, Tacke F. Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery. Int J Mol Sci. 2017;18(8):1662.

Article  PubMed  PubMed Central  Google Scholar 

Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, Struck J, Bergmann A, Hartmann O, Di Somma S. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017;37(5):388–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng LL, Squire IB, Jones DJL, Cao TH, Chan DCS, Sandhu JK, Quinn PA, Davies JE, Struck J, Hartmann O, et al. Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study. J Am Coll Cardiol. 2017;69(1):56–69.

Article  CAS  PubMed  Google Scholar 

Hollinger A, Wittebole X, François B, Pickkers P, Antonelli M, Gayat E, Chousterman BG, Lascarrou JB, Dugernier T, Di Somma S, et al. Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the kidney in sepsis and septic shock (Kid-SSS) study. Kidney Int Rep. 2018;3(6):1424–33.

Article  PubMed  PubMed Central  Google Scholar 

Molvin J, Jujic A, Navarin S, Melander O, Zoccoli G, Hartmann O, Bergmann A, Struck J, Bachus E, Di Somma S, et al. Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting. Open Heart. 2019;6(2):e001048.

Article  PubMed  PubMed Central  Google Scholar 

Liu R, Zheng X, Wang H, Wang S, Yu K, Wang C. The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients. Crit Care. 2020;24(1):162.

Article  PubMed  PubMed Central  Google Scholar 

Lima C, Gorab DL, Fernandes CR, Macedo E. Role of proenkephalin in the diagnosis of severe and subclinical acute kidney injury during the perioperative period of liver transplantation. Pract Lab Med. 2022;31:e00278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao HL, Hu HJ, Zhao XJ, Chi WW, Liu DM, Wang Q, Cui W. Urine N-terminal pro-B-type natriuretic peptide and plasma proenkephalin are promising biomarkers for early diagnosis of cardiorenal syndrome type 1 in acute decompensated heart failure: a prospective, double-center, ob